"Quick cycle" neoadjuvant chemotherapy in squamous cell carcinoma of cervix

Indian Journal of Pharmacology

Volumn 37, Issue 5, 2005, Pages 320-324

  Taneja, A ^a   Rajaram, S ^b,d   Agarwal, S ^b   Singh, K C ^b   Sahni, S ^c   Goel, N ^b  

^a DAYANAND MEDICAL COLLEGE AND HOSPITAL   (India)

^b UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

^c Cytogenetics Department   (India)

^d B 704 Gitanjali Apartments ^*  (India)

Author keywords

Cancer cervix; SCC Antigen; Tumor marker

Indexed keywords

BLEOMYCIN; CISPLATIN; CREATININE; HEMOGLOBIN; SQUAMOUS CELL CARCINOMA ANTIGEN; TUMOR MARKER; VINCRISTINE;

ABNORMALLY LOW SUBSTRATE CONCENTRATION IN BLOOD; ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; NAUSEA AND VOMITING; RADICAL HYSTERECTOMY; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; THROMBOCYTE; THROMBOCYTE COUNT; TREATMENT OUTCOME; TUMOR VOLUME; UREA BLOOD LEVEL; UTERINE CERVIX CARCINOMA;

EID: 26444533937     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: 10.4103/0253-7613.16857     Document Type: Article

References (19)

1. Rajkumar R, Sankaranarayanan R, Esmi A, Jayaraman R, Cherian J, Parkin DM. Leads to cancer control based on cancer patterns in a rural population in South India. Cancer Causes Control 2000;11:433-9.
2. Rao DN, Ganesh B. Estimate of Cancer Incidence in India 1991. Indian J Cancer 1998;35:10-8.
3. Cannistra SA, Niloff JN. Cancer of the uterine cervix. New Eng J Med 1996;334:1030-8.
4. Lin H, ChangChien CCC, Huang EY, Tseng CW, Eng HL, Huang CC. The role of pretreatment squamous cell carcinoma antigen in predicting nodal metastasis in early stage cervical cancer. Acta Obstet Gynecol Scand 2000;79:140-4.
5. Sardi J, Sananes C, Giaroli A, Maya G, Paola D. Neoadjuvant Chemotherapy in locally advanced carcinoma of the cervix uteri. Gynecol Oncol 1990;38:486-93.
6. Sardi JE, Giaroli A, Sananes C, Ferreira M, Soderini A, Bermudez A, et al. Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results. Gynecol Oncol 1997;67:61-9.
7. Napolitano U, Imperato F, Mossa B, Framarino ML, Marziani R, Marzetti L. The role of neoadjuvant chemotherapy for squamous cell cervical cancer (Ib-IIIb): A long-term randomized trial. Eur J Gynaecol Oncol 2003;24:51-9.
8. Kumar L. Role of Chemotherapy in advanced squamous cell cervical carcinoma. Oncol Forum 1998;2:3-10.
9. Micke O, Prott FJ, Schafer U, Tangerding S, Potter R, Willich N. The impact of squamous cell carcinoma (SCC) antigen in the follow-up after radiotherapy in patients with cervical cancer. Anticancer Res 2000;20:5113-5.
10. Gaarenstroon KN, Kenter GG, Bonfrer JM, Korse CM, Van de Viiver MJ, Fleuren GJ, et al. Can initial Serum Cyfra 21-1, SCC Antigen, and TPA Levels in Squamous Cell Cervical Cancer Predict Lymph Node Metastases or Prognosis? Gynecol Oncol 2000;77:164-70.
11. de Bruijn HW, Duk JM, van der Zee AG, Pras E, Willemse PH, Boonstra H, et al. The clinical value of squamous cell carcinoma antigen in cancer of uterine cervix. Tumor Biol 1998;19:505-16.
12. Ohno T, Nakayama N, Nakamoto S, Kato S, Imai R, Nonako T, et al. Measurement of serum squamous cell carcinoma antigen levels as a predictor of radiation response in patients with carcinoma of the uterine cervix. Cancer 2003;97:3114-20.
13. Capalash N, Sobiti RC. Epidemiology of cervical cancer. A case control study on North Indian population. Indian J Cancer 1999;36:179-85.
14. Serur E, Mathews RP, Gates J, Levine P, Maiman M, Remy JC. Neoadjuvant chemotherapy in stages IB2 squamous cell carcinoma of the cervix. Gynecol Oncol 1997;65:348-56.
15. Seoud M, Geara FB, Shamseddine A, Salem Z, Khalil A. Short duration neoadjuvant chemotherapy followed by radiotherapy for advanced carcinoma of cervix: Results and prognostic variables. Eur J Gynecol Oncol 2003;24:163-8.
16. Huang HJ, Chang TC, Hong JH, Tseng CJ, Chou HH, Huang KG, et al. Prognostic value of age and histologic type in neoadjuvant chemotherapy plus radical surgery for bulky (>/=4 cm) stage IB and IIA cervical carcinoma. Int J Gynecol Cancer 2003;13:204-11.
17. Porzio G, Ficorella C, Toro G, Paris I, Ricevuto E, Marchetti P. Short-term weekly neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer. Tumori 2001;87:25-6.
18. Kumar L, Kaushal R, Nandy M, Biswal BM, Kumar S, Kriplani A, et al. Chemotherapy followed by radiotherapy versus radiotherapy alone in locally advanced cervical cancer: A randomized study. Gynecol Oncol 1994;54:302-15.
19. Juang CH, Wang PH, Yen MS, Yen MS, Lai CR, Ng HT, et al. Application of tumor Markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix. Gynecol Oncol 2000;76:103-6.